The Global Thrombectomy Devices Market Size is growing at a CAGR of 6.83% by 2032, estimates DelveInsight

DelveInsight's Thrombectomy Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Thrombectomy Devices Companies market shares, challenges, Thrombectomy Devices Market Drivers, barriers, trends, and key market Thrombectomy Devices companies in the market.

To read more about the latest highlights related to the Thrombectomy Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Thrombectomy Devices Market Report
• In September 2025, Imperative Care received FDA 510(k) clearance for its Symphony® Thrombectomy System to treat pulmonary embolism (PE), expanding its use from venous thrombosis to cover the full spectrum of venous thromboembolism (VTE) patient care.
• In July 2025, Imperative Care received FDA 510(k) clearance for its Zoom 7X Catheter, a new tool for aspiration thrombectomy in ischemic stroke. As part of the Zoom Stroke System, the catheter features CenTRXTM Technology with a 96-degree pre-shaped tip designed to center in vessels and improve clot removal by optimizing aspiration in challenging anatomy.
• In February 2025, Stryker completed the acquisition of Inari Medical, Inc., significantly strengthening its position in the thrombectomy market. Inari's product portfolio, including the FlowTriever® System for pulmonary embolism and the ClotTriever® System for peripheral vessel thrombectomy, is highly complementary to Stryker's existing Neurovascular business.
• In February 2025, the TendviaTM Pulmonary Artery Thrombectomy System from Shanghai Tendfo Medical Device Co., Ltd. received approval from the China National Medical Products Administration (NMPA). The device is indicated for transcatheter thrombectomy in patients with acute high-risk or intermediate-risk pulmonary embolism, offering a minimally invasive treatment option for these critical conditions.
• The Global Thrombectomy Devices Market is expected to increase from ~USD 1650 Million in 2024 to ~USD 2800 Million by 2032, reflecting strong and sustained growth.
• The Global Thrombectomy Devices Market is growing at a CAGR of 6.83% during the forecast period from 2025 to 2032.
• North America is expected to hold the largest share of the thrombectomy devices market in 2024, driven by several key factors. The region's dominance can be attributed to the high prevalence of neurovascular, peripheral, and coronary vascular diseases, the rapidly growing geriatric population, and the continuous innovation and product launches by leading medical device companies based in the region. These elements, combined with advanced healthcare infrastructure, favorable reimbursement policies, and increasing awareness of minimally invasive procedures, are expected to sustain North America's leading position in the global market.
• The leading Thrombectomy Devices Companies such as Stryker, Abbott Laboratories, Boston Scientific Corporation, Argon Medical Devices, Contego Medical, Inc., Mermaid Medical, Surmodics, Inc., Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., Edwards Lifesciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroPort Scientific Corporation, Thrombolex, phenox GmbH, Acandis GmbH, Innova Vascular, Vesalio Inc., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., and others.

To know more about why North America is leading the market growth in the Thrombectomy Devices Market, get a snapshot @ https://www.delveinsight.com/sample-request/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Thrombectomy Devices Market Dynamics
According to the British Heart Foundation (2024), an estimated 56 million women and 45 million men worldwide were stroke survivors, reflecting the immense global burden of cerebrovascular disease. The same source also reported that, as of 2022, nearly 250 million people globally were living with coronary heart disease, further emphasizing the need for effective interventional solutions. Similarly, data from the World Stroke Organization (2023), highlighted that one in four adults over the age of 25 would suffer a stroke in their lifetime, and over 110 million individuals worldwide had already experienced one. Thrombectomy devices play a vital role in restoring blood flow by physically removing blood clots that obstruct arteries or veins, especially in acute, life-threatening conditions such as ischemic stroke or peripheral arterial thrombosis.

Thrombectomy Devices Market Segment Analysis
Thrombectomy Devices Market by Product (Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, Ultrasonic Thrombectomy Devices, and Others), Application (Peripheral Vascular Thrombectomy, Coronary Vascular Thrombectomy, and Neurovascular Thrombectomy), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). In the product segment of the thrombectomy devices market, the mechanical thrombectomy devices category is estimated to account for the largest market share in 2024. This can be primarily attributed to the rising prevalence of cardiovascular disorders (CVDs) such as strokes. Additionally, various advantages and applications provided by these devices could also raise the demand for the category.

Get a sneak peek at the Thrombectomy Devices Market Dynamics @ Thrombectomy Devices Market Dynamics Analysis- https://www.delveinsight.com/sample-request/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Thrombectomy Devices Companies
Stryker, Abbott Laboratories, Boston Scientific Corporation, Argon Medical Devices, Contego Medical, Inc., Mermaid Medical, Surmodics, Inc., Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., Edwards Lifesciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroPort Scientific Corporation, Thrombolex, phenox GmbH, Acandis GmbH, Innova Vascular, Vesalio Inc., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., and others.

Thrombectomy Devices Market Drivers
The growing demand for thrombectomy devices is driven by several key factors supporting strong market growth. The rising global prevalence of neurological and cardiovascular conditions such as acute ischemic stroke, pulmonary embolism, and deep vein thrombosis, among others necessitate timely, effective interventions. Additionally, there is a clear shift toward minimally invasive treatment options, preferred by both patients and healthcare providers. Further fueling growth is continuous innovation and product launches by leading players, which are investing in advanced technologies and launching next-generation products that enhance procedural efficiency and outcomes. Collectively, these trends are creating a favorable environment for sustained market expansion from 2025 to 2032.

Which MedTech key players in the Thrombectomy Devices Market are set to emerge as the trendsetter explore @ Thrombectomy Devices Companies- https://www.delveinsight.com/sample-request/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Thrombectomy Devices Market Report
• Coverage- Global
• Forecast Period- 2025-2032
• Thrombectomy Devices Companies- Stryker, Abbott Laboratories, Boston Scientific Corporation, Argon Medical Devices, Contego Medical, Inc., Mermaid Medical, Surmodics, Inc., Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., Edwards Lifesciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroPort Scientific Corporation, Thrombolex, phenox GmbH, Acandis GmbH, Innova Vascular, Vesalio Inc., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., and others.

Interested in knowing the Thrombectomy Devices Market by 2032? Click to get a snapshot of the Thrombectomy Devices Market Trends- https://www.delveinsight.com/sample-request/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Thrombectomy Devices Market Report Introduction
2. Thrombectomy Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Thrombectomy Devices Market Key Factors Analysis
6. Thrombectomy Devices Market Porter's Five Forces Analysis
7. Thrombectomy Devices Market Assessment
8. Thrombectomy Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

About Us

DelveInsight is a leading focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and pharma sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.